Literature DB >> 2663890

Developmentally regulated 75-kilodalton protein expressed in LLC-PK1 cultures is a component of the renal Na+/glucose cotransport system.

J S Wu1, J E Lever.   

Abstract

Na+/D-glucose symport is a secondary active glucose transport mechanism expressed only in kidney proximal tubule and in small intestine. A monoclonal antibody that recognized the Na+/glucose symporter of pig renal brush border membranes also recognized a 75-kD protein in apical membranes isolated from highly differentiated LLC-PK1 cultures, an epithelial cell line of pig renal proximal tubule origin. The 75-kD antigen was enriched from solubilized LLC-PK1 apical membranes by means of high-pressure liquid chromatography. The symporter antigen became apparent on the apical membrane surface after the development of a confluent monolayer in correlation with the expression of transport activity. Long-term treatment of cultures with the differentiation inducer hexamethylene bisacetamide was accompanied by a dramatically increased expression of the symporter antigen as detected quantitatively by Western blot analysis and qualitatively by immunofluorescence staining. The number of symporter-positive cells was dramatically increased after inducer treatment as predicted for differentiation-regulated expression. These results identify a 75-kD protein as a component of a developmentally regulated renal Na+/glucose symporter expressed in cell culture.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2663890     DOI: 10.1002/jcb.240400109

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  2 in total

1.  Differentiation-dependent expression of the Na+/glucose cotransporter (SGLT1) in LLC-PK1 cells: role of protein kinase C activation and ongoing transcription.

Authors:  T Shioda; T Ohta; K J Isselbacher; D B Rhoads
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

2.  IDH mutant gliomas escape natural killer cell immune surveillance by downregulation of NKG2D ligand expression.

Authors:  Xiaoran Zhang; Aparana Rao; Paola Sette; Christopher Deibert; Alexander Pomerantz; Wi Jin Kim; Gary Kohanbash; Yigang Chang; Yongseok Park; Johnathan Engh; Jaehyuk Choi; Timothy Chan; Hideho Okada; Michael Lotze; Paola Grandi; Nduka Amankulor
Journal:  Neuro Oncol       Date:  2016-04-25       Impact factor: 12.300

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.